Treatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideDoxorubicinNeoplasm StagingDisease-Free SurvivalPrognosisNeoadjuvant TherapySurvival AnalysisSurvival RateNeoplasm Recurrence, LocalLung NeoplasmsBreast NeoplasmsEtoposideDrug Administration ScheduleMethotrexateAdenocarcinomaCarboplatinFollow-Up StudiesLiver NeoplasmsInduction ChemotherapyPaclitaxelVinblastineStomach NeoplasmsNeoplasmsTaxoidsAntimetabolites, AntineoplasticIfosfamideDrug Resistance, NeoplasmColorectal NeoplasmsOrganoplatinum CompoundsDeoxycytidineBleomycinRadiotherapy, AdjuvantTime FactorsNeoplasm MetastasisCarcinoma, Non-Small-Cell LungPalliative CareSalvage TherapyGastrectomyRadiotherapyLymphatic MetastasisCytarabineAntineoplastic Agents, AlkylatingAnthracyclinesKaplan-Meier EstimateRectal NeoplasmsChemotherapy, Cancer, Regional PerfusionProspective StudiesOvarian NeoplasmsTesticular NeoplasmsTumor Markers, BiologicalTransplantation, AutologousHodgkin DiseaseRecurrenceLymphoma, Non-HodgkinClinical Trials as TopicNeutropeniaAntineoplastic Agents, PhytogenicHematopoietic Stem Cell TransplantationHepatectomyCarcinoma, Squamous CellVomitingPeritoneal NeoplasmsRadiotherapy DosageNauseaCarcinomaPancreatic NeoplasmsAntibiotics, AntineoplasticMitomycinMultivariate AnalysisBone NeoplasmsNeoplasms, Germ Cell and EmbryonalCamptothecinGranulocyte Colony-Stimulating FactorBrain NeoplasmsEsophageal NeoplasmsDacarbazineCarcinoma, HepatocellularTegafurChemoradiotherapyCarmustineInfusions, Intra-ArterialOsteosarcomaLeukopeniaLomustineCell Line, TumorDisease ProgressionTomography, X-Ray ComputedPlatinum CompoundsDrug TherapyDose-Response Relationship, DrugRandomized Controlled Trials as TopicInfusions, IntravenousColonic NeoplasmsAntibodies, Monoclonal, Humanized